Hepatocyte‐specific high‐mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high‐mobility group box 1 in cellular protection
暂无分享,去创建一个
Xiaorong Zhu | T. Billiar | E. Chang | A. Tsung | P. Loughran | D. Beer‐Stolz | Kerry-Ann McDonald | Hai Huang | J. Klune | S. Tai | B. Rosborough | G. Nace | Qing Ding
[1] D. Stolz,et al. Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice , 2013, Hepatology.
[2] P. A. Friedman,et al. PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes. , 2013, Nitric oxide : biology and chemistry.
[3] Wentao Gao,et al. Caspase 1 Activation Is Protective against Hepatocyte Cell Death by Up-regulating Beclin 1 Protein and Mitochondrial Autophagy in the Setting of Redox Stress* , 2013, The Journal of Biological Chemistry.
[4] J. Bass,et al. ROS‐Mediated PARP Activity Undermines Mitochondrial Function After Permeability Transition Pore Opening During Myocardial Ischemia–Reperfusion , 2013, Journal of the American Heart Association.
[5] S. Henikoff,et al. Regulation of nucleosome dynamics by histone modifications , 2013, Nature Structural &Molecular Biology.
[6] W. Kraus,et al. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs , 2012, Nature Reviews Molecular Cell Biology.
[7] O. Dirsch,et al. Hepatic Arterial Perfusion Is Essential for the Spontaneous Recovery From Focal Hepatic Venous Outflow Obstruction in Rats , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] M. Lotze,et al. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. , 2011, Antioxidants & redox signaling.
[9] C. Esmon,et al. Endogenous Histones Function as Alarmins in Sterile Inflammatory Liver Injury Through Toll-like Receptor 9 in Mice , 2011, Hepatology.
[10] J. Karliner,et al. Minocycline Protects Cardiac Myocytes Against Simulated Ischemia–Reperfusion Injury by Inhibiting Poly(ADP-ribose) Polymerase-1 , 2010, Journal of Cardiovascular Pharmacology.
[11] S. Kaufmann,et al. PARP inhibition: PARP1 and beyond , 2010, Nature Reviews Cancer.
[12] G. Plitas,et al. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. , 2010, Journal of Clinical Investigation.
[13] R. Aguilar-Quesada,et al. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. , 2009, Free Radical Biology & Medicine.
[14] Sabine S. Lange,et al. HMGB1: The jack‐of‐all‐trades protein is a master DNA repair mechanic , 2009, Molecular carcinogenesis.
[15] Sabine S. Lange,et al. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage , 2008, Proceedings of the National Academy of Sciences.
[16] T. Billiar,et al. HMGB1: Endogenous Danger Signaling , 2008, Molecular medicine.
[17] M. Rosengart,et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.
[18] A. Blázovics,et al. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status. , 2007, The Journal of surgical research.
[19] M. Lotze,et al. Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.
[20] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[21] M. Hande,et al. Yeast Nhp6A/B and Mammalian Hmgb1 Facilitate the Maintenance of Genome Stability , 2005, Current Biology.
[22] M. Evans,et al. Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] R. Busuttil,et al. Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.
[24] S. Cuzzocrea,et al. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. , 2002, Medical Science Monitor.
[25] P. Biberthaler,et al. Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury. , 2002, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[26] D. Stolz,et al. Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. , 1999, The American journal of pathology.
[27] A. Aguzzi,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.
[28] V. Dawson,et al. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.
[29] M. Smerdon,et al. Changes in nuclear protein acetylation in u.v.-damaged human cells. , 1986, Carcinogenesis.
[30] J. Wang,et al. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. , 1978, Science.
[31] S. Ryter,et al. Mechanisms of cell death in oxidative stress. , 2007, Antioxidants & redox signaling.
[32] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.